Accordingly, the decline in SIRT1 serum levels is a promising marker for early detection of endocrine and metabolic diseases [17], Alzheimer’s disease [18], cardiovascular disease [19], etc., and SIRT1 is reputedly a frailty-related biomarker [20]. Here, SIRT1 is linked to early-onset autosomal dominant Alzheimer disease.